mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.069 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |